Lone Star Oncology
2025 Annual Fall Conference, Advances in Precision Oncology
- Registration Closed
Audience: Oncologists, Oncology Nurses, Oncology APPs, Oncology Pharmacists.
Location: Crowne Plaza Houston Med Ctr-Galleria Area, 2712 Southwest Fwy, Houston, TX 77098
Date: Friday, September 12, 2025 - Saturday, September 13, 2025
This Conference is in-person only, no virtual options.
Note:
1. We are unable to accommodate onsite registration. To attend, please register online (via the registration link).
2. This program is supported by a limited grant/sponsorship in support of oncology advancement, education, and oncology professional development. Therefore, we have limited spots for non-exhibiting industry partners. Industry partners should email star@lonestaroncology.org for any availability.
Accreditation NCPD/CE
Lone Star Oncology is approved as a provider of nursing continuing professional development by the Louisiana State Nurses Association - Approver, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 8.0 contact hours and 2.5 Pharmacotherapeutic contact hours
To receive contact hours for this nursing continuing professional development activity, the participant must:
● Sign in.
● Attend and be present for the entire presentation. No partial credit will be provided.
● Complete the evaluation after the presentation via a link provided to all participants.
● Certificates will be awarded electronically upon completion of the evaluation.
Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for 8.0 NCPD contact hours and 2.5 Pharmacotherapeutic contact hours.
Accommodation/Hotel Reservation
The conference will take place at the Crowne Plaza Houston Med Ctr-Galleria Area, 2712 Southwest Fwy, Houston, TX 77098.
Conference attendees will receive a significantly discounted hotel rate. The reservation cut-off date is Aug. 28th, 2025.
Reserve your room directly here - Hematology Conference Sept. 2025
Lone Star Oncology reserves the right to update this information and decline participation as deemed necessary.
Kaiwen Wang, Pharm D
MD Anderson Cancer Center
Chibuokem (Chib) Amuneke-Nze, PharmD, MBA
MD Anderson Cancer Center
Funda Meric-Bernstam MD
MD Anderson Cancer Center
Stephanie Chen, MD
Houston Methodist
Ashley Martinez, DNP, APRN, FNP-BC, AOCNP, CPHQ, NEA-BC, NPD-BC
MD Anderson Cancer Center
Vipal Durkal, MD
Texas Oncology
Neha Maithel, MD
University of Texas Medical School at Houston
Taiwo Adesoye, MD, MPH
MD Anderson Cancer Center
Anishia Sulaiman Rawther –Karedath: MS RN AGNP-BC
MD Anderson Cancer Center
Kat Grannemann, MSN, RN, OCN
Houston Methodist
Allison Gibson
Houston Methodist
Lauren Perez, DNP, APRN, FNP-C, AOCNP, TTS
MD Anderson Cancer Center
Cyrus A. Iqbal, M.D.
Kelsey Seybold
Sandra Musekiwa-Adjei, DNP, FNP-C
MD Anderson Cancer Center
Maurice Willis, MD
UTMB Health
Click to download the conference agenda
| Friday September 12, 2025 | ||
| 4:30 PM | Registration/Exhibit Open | |
| 5:30 PM | Welcome/Registration/Networking | |
| 6:00 PM | Dinner/Freshments | |
| 6:20 PM | Oncology Therapeutics: Current Landscape & Future Horizons | Kaiwen Wang, PharmD, BCOP. Clinical Oncology Pharmacist, MD Anderson Cancer Center Chibuokem (Chib) Amuneke-Nze, PharmD, MBA Inpatient Assist. Manager, MD Anderson Cancer Center |
| 7:50 PM | Networking/Exhibit | |
| 8:20 PM | Friday Conclusion | |
| Saturday September 13, 2025 | ||
| 7:30 AM | Registration/Breakfast | |
| 7:55 AM | Attendee Information | |
| 8:00 AM | Interpreting Molecular Reports and Identifying Tumor Agnostic Targets | Funda Meric-Bernstam, MD. Chair of the Department of Investigational Cancer Therapeutics. Medical Director of the Institute of Personalized Cancer Therapy MD Anderson Cancer Canter |
| 8:30 AM | Head and Neck Cancer Prevention: Focus on HPV, Oral, and Thyroid Cancers | Stephanie Chen, MD Head and Neck Surgery Head and Neck Surgical Oncology Houston Methodist |
| 9:00 AM | Managing Malignancy in Pregnancy: Chemotherapy Considerations | Ashley Martinez, DNP, APRN, FNP-BC, AOCNP, CPHQ, NEA-BC, NPD-BC Director, Advanced Practice, Advanced Practice Programs The University of Texas MD Anderson Cancer Center |
| 9:30 AM | Advances in Pancreatic Cancer Care | Vipal Durkal, M.D Hematology Medical Oncology Texas Oncology |
| 10:00 AM | Break | |
| 10:20 AM | Latest Insights & Strategies in Colorectal Cancers | Neha Maithel, MD Assistant Professor Genitourinary and Gastrointestinal Oncology. Department of Medical Oncology University of Texas Medical School at Houston |
| 11:05 AM | Optimizing Outcomes in Inflammatory Breast Cancer: Latest Updates and Clinical Applications | Taiwo Adesoye, MD, MPH Assistant Professor, Department of Breast Surgical Oncology Program Director, Breast Surgical Oncology Observer Program UT MD Anderson Cancer Center |
| 11:50 PM | Transition Break | |
| 12:00 PM | Lunch/ breakout sessions | |
| 12:50 PM | Transition Break | |
| 1:20 PM | Concurrent A The Evolving Landscape of Prostate Cancer and Patient Management | Anishia Rawther-Karedath APRN, MSN Supervisor, Inpatient Advanced Practice Providers MD Anderson Cancer Center |
| Concurrent B Get Your Move On! Empowering Patients with Physical Activity to Combat Cancer-Related Fatigue | Katherine Grannemann MSN, RN, OCN Oncology Nurse Navigator Allison Gibson BSN, OCN Houston Methodist Neal Cancer Center | |
| Concurrent C Patient-Centric Radiation Oncology Management | Lauren Perez, DNP, APRN, FNP-C, AOCNP, TTS Nurse Practitioner, Medical Oncology MD Anderson Cancer Center | |
| 2:05 PM | Transition Break | |
| 2:10 PM | Bladder Cancer: Updates, Strategies, and Personalized Care | Cyrus A. Iqbal, M.D. Hematology & Medical Oncology Kelsey Seybold Cancer Center |
| 2:40 PM | Emerging Therapeutic Strategies in Clinical Trials: A Comparative Look at Glioma, Gastroesophageal Junction Cancers, and Gall Bladder. | Sandra Musekiwa-Adjei, DNP, FNP-C Advanced Practice Registered Nurse General Oncology Phase 1 MD Anderson Cancer Center |
| 3:20 PM | Break | |
| 3:30 PM | Precision, Progress, and Practice: Evolving Landscape in Lung Cancer | Maurice Willis MD Chief of Medical Oncology and Hematology, UTMB Health, Galveston |
| 4:15 PM | Conference Conclusion/Evaluation Information | |
Planners
Maribel Bhojani, DNP, MSHSA, BSN, RN, NPD-BC
Roselyn Ogunkunle, PhD, MSN, RN, NEA-BC, OCN
Cassandra Green, DNP, RN, OCN
Meghan Jones, MSN, RN, OCN, NPD-BC
Deidra Deslattes BSN, RN, OCN
Thank You Exhibitors & Sponsors!
Conference Sponsor - The PCP Groups
Diamond Level - Jazz Pharmaceuticals, Inc. GSK
Gold Level - Syndax Exact Sciences SpringWorks Therapeutics SOBI North America
Silver Level - AstraZeneca Nursing Education Nuvation Bio Merck Incyte AstraZeneca Pharmaceuticals Daiichi Sankyo IPSEN Biopharmaceuticals, Inc.